PacBio has announced a new study published in Nature Communications that presents an innovative method for analyzing complex regions of the human genome, particularly segmental duplications that have ...

PacBio announced its involvement in a groundbreaking study published in Nature Genetics, which utilized its advanced sequencing technology to explore the genetic basis of a rare Mendelian condition in ...

Paraphase Enables Researchers to Analyze Genes That are Critically Relevant but Hard to Genotype MENLO PARK, Calif., March 14, 2023 /PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of highly ...

PACB launched SPRQ-Nx and multi-use SMRT Cells for Revio, lowering sequencing costs by about 30%. PacBio says SPRQ-Nx can push human genome sequencing costs below $300 at scale. PACB upgraded ...

MENLO PARK, Calif., Aug. 04, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced the results of a study published ...

PacBio recently announced CiFi, a community-developed method that integrates chromatin conformation capture with HiFi long-read sequencing to deliver chromosome-scale, haplotype-resolved genome ...

MENLO PARK, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced its entry into the ...

PACB launched a joint FFPE workflow with Covaris to improve the sequencing of archived tumor samples. The solution enhances DNA recovery, boosting structural variant detection and mutation phasing ...

MENLO PARK, Calif., May 22, 2025 (GLOBE NEWSWIRE) -- PacBio (PACB), a leading provider of high-quality, highly accurate sequencing solutions, today announced the appointment of Haorui Gene, a globally ...

PacBio PACB recently announced the worldwide commercial availability of its SPRQ-Nx sequencing chemistry and new multi-use SMRT Cells for the Revio HiFi sequencing platform. The launch is expected to ...